We are a biotechnology company specialized in research and development of new immunological treatments for application in human and animal health to treat and prevent infectious, inflammatory and autoimmune diseases. We have strategic partners in the public sector, headed by the Center for Molecular Biology Severo Ochoa (CBMSO) of Madrid, and highly prestigious private and pharmaceutical companies.
Our strong partnerships have facilitated the rapid development of our major projects, and a considerable know-how that we make available to our customers. Our multidisciplinary team is our most important asset, highly dedicated and committed to achieve the projected research goals, and driven by the enthusiasm to provide a benefit to society with our products.
Currently we are certifying the quality of our services through Good Practices Laboratory (GLP), to make it available to our customers as quickly as possible.